Cefotaxime Sodium Powder, for Solution
Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Demand increase for the drug
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 02/17/2015
- Package NDC
- 0143-9933-25
- Generic name
- Cefotaxime Sodium Powder, for Solution
- Contact info
- 800-631-2174
- Availability
- Unavailable
- Related info
- Estimated recovery: TBD
- Update date
- 09/18/2026
- Dosage form
- Powder, For Solution
- Presentation
- Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 0143-9933-25)
- Company name
- Hikma Pharmaceuticals USA, Inc.
- Shortage reason
- Demand increase for the drug
- Status
- Current
- Therapeutic category
- Anti-Infective, Pediatric
- Harmonized identifiers (openFDA)
- Application number
- ANDA065072
- Brand name
- CEFOTAXIME
- Generic name
- CEFOTAXIME
- Manufacturer name
- Hikma Pharmaceuticals USA Inc.
- Product NDC
- 0143-9933, 0143-9931, 0143-9930
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Substance name
- CEFOTAXIME SODIUM
- RxCUI
- 309068, 1656313, 1656318
- SPL ID
- 7e0897ec-2275-4438-9cc5-4c951e52ad97
- SPL set ID
- ed23b6bc-32c7-4c50-a53d-313ae78e5623
- Package NDC
- 0143-9931-01, 0143-9931-25, 0143-9933-01, 0143-9933-25, 0143-9930-01, 0143-9930-10
- UNII
- 258J72S7TZ